Evidence map›Paper›PMID 16983387›Full record

ReviewNature chemical biology2006

Therapeutic intervention based on protein prenylation and associated modifications.

Michael H Gelb, Lucas Brunsveld, Christine A Hrycyna, Susan Michaelis, Fuyuhiko Tamanoi, Wesley C Van Voorhis, Herbert Waldmann

Open access · greenAbstract readReview
In one paragraph

Review in Nature chemical biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 191 citations in OpenAlex.

  1. Phytochemistry and Pharmacological Potential of the GenusPharmaceuticals (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. De Novo Discovery of Prenylated Macrocyclic Peptide Ligands.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Michael H GelbDepartment of Chemistry, University of Washington, Seattle, Washington 98195, USA. gelb@chem.washington.edu
Lucas Brunsveld
Christine A Hrycyna
Susan Michaelis
Fuyuhiko Tamanoi
Wesley C Van Voorhis
Herbert Waldmann
Max Planck Institute of Molecular Physiology · DEUniversity of Washington · USJohns Hopkins Medicine · USPurdue University West Lafayette · USUniversity of California, Los Angeles · US

Funding

T-LYMPHOCYTE-DERIVED ERYTHROID-POTENTIATING ACTIVITYP01CA032737 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SLAMON, DENNIS J · 1985 to 2006
$8.9M
Biochemistry of Protein PrenylationR01AI054384 · NIAID · UNIVERSITY OF WASHINGTON · PI BUCKNER, FREDERICK SIMMONS, GELB, MICHAEL H · 2003 to 2012
$5.3M
The integral membrane protease ZMPSTE24, lamin A processing, and progeriaR01GM041223 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI MICHAELIS, SUSAN D. · 1989 to 2017
$5.0M
STRUCTURAL &FUNCTIONAL ANALYSES OF YEAST RAS PROTEINSR01CA041996 · NCI · UNIVERSITY OF CHICAGO · PI TAMANOI, FUYUHIKO · 1985 to 2014
$4.6M
NCI NIH HHS CA32737NCI NIH HHS CA41996NCI NIH HHS P01 CA032737NCI NIH HHS R01 CA041996NIAID NIH HHS AI054384NIAID NIH HHS R01 AI054384NIGMS NIH HHS GM41223NIGMS NIH HHS R01 GM041223
6 · The paper itself

Abstract

In eukaryotic cells, a specific set of proteins are modified by C-terminal attachment of 15-carbon farnesyl groups or 20-carbon geranylgeranyl groups that function both as anchors for fixing proteins to membranes and as molecular handles for facilitating binding of these lipidated proteins to other proteins. Additional modification of these prenylated proteins includes C-terminal proteolysis and methylation, and attachment of a 16-carbon palmitoyl group; these modifications augment membrane anchoring and alter the dynamics of movement of proteins between different cellular membrane compartments. The enzymes in the protein prenylation pathway have been isolated and characterized. Blocking protein prenylation is proving to be therapeutically useful for the treatment of certain cancers, infection by protozoan parasites and the rare genetic disease Hutchinson-Gilford progeria syndrome.

Indexed as

Protein PrenylationAnimalsAntineoplastic AgentsHumansModels, MolecularMolecular ConformationProgeriaProteinsAntineoplastic AgentsProteins

Identifiers

PMID16983387
PMCPMC2892741
OpenAlexW2022454349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.